Detalles de la búsqueda
1.
Effectiveness of Immunization Products Against Medically Attended Respiratory Syncytial Virus Infection: Generic Protocol for a Test-Negative Case-Control Study.
J Infect Dis;
229(Supplement_1): S92-S99, 2024 Mar 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-37935046
2.
Higher-valency pneumococcal conjugate vaccines in older adults, taking into account indirect effects from childhood vaccination: a cost-effectiveness study for the Netherlands.
BMC Med;
22(1): 69, 2024 Feb 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-38360645
3.
Effectiveness of Omicron XBB.1.5 vaccine against infection with SARS-CoV-2 Omicron XBB and JN.1 variants, prospective cohort study, the Netherlands, October 2023 to January 2024.
Euro Surveill;
29(10)2024 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-38456217
4.
Early COVID-19 vaccine effectiveness of XBB.1.5 vaccine against hospitalisation and admission to intensive care, the Netherlands, 9 October to 5 December 2023.
Euro Surveill;
29(1)2024 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-38179623
5.
Vaccine Effectiveness Against Severe Acute Respiratory Syndrome Coronavirus 2 Delta and Omicron Infection and Infectiousness Within Households in the Netherlands Between July 2021 and August 2022.
J Infect Dis;
228(4): 431-438, 2023 08 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-37093964
6.
Higher risk of SARS-CoV-2 Omicron BA.4/5 infection than of BA.2 infection after previous BA.1 infection, the Netherlands, 2 May to 24 July 2022.
Euro Surveill;
28(7)2023 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-36795499
7.
Effectiveness of bivalent mRNA booster vaccination against SARS-CoV-2 Omicron infection, the Netherlands, September to December 2022.
Euro Surveill;
28(7)2023 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-36795500
8.
Vaccine effectiveness against COVID-19 hospitalisation in adults (≥â¯20 years) during Alpha- and Delta-dominant circulation: I-MOVE-COVID-19 and VEBIS SARI VE networks, Europe, 2021.
Euro Surveill;
28(47)2023 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-37997666
9.
Vaccine effectiveness against COVID-19 hospitalisation in adults (≥â¯20 years) during Omicron-dominant circulation: I-MOVE-COVID-19 and VEBIS SARI VE networks, Europe, 2021 to 2022.
Euro Surveill;
28(47)2023 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-37997665
10.
Vaccine Impact and Effectiveness of Meningococcal Serogroup ACWY Conjugate Vaccine Implementation in the Netherlands: A Nationwide Surveillance Study.
Clin Infect Dis;
74(12): 2173-2180, 2022 07 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-34525199
11.
Serotype Replacement after Introduction of 10-Valent and 13-Valent Pneumococcal Conjugate Vaccines in 10 Countries, Europe.
Emerg Infect Dis;
28(1): 137-138, 2022 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34932457
12.
Sex differences in COVID-19 mortality in the Netherlands.
Infection;
50(3): 709-717, 2022 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-35138581
13.
Incidence and severity of SARS-CoV-2 infection in former Q fever patients as compared to the Dutch population, 2020-2021.
Epidemiol Infect;
150: e116, 2022 06 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-35730315
14.
Increased risk of infection with SARS-CoV-2 Omicron BA.1 compared with Delta in vaccinated and previously infected individuals, the Netherlands, 22 November 2021 to 19 January 2022.
Euro Surveill;
27(4)2022 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-35086609
15.
COVID-19 vaccine effectiveness against SARS-CoV-2 infection during the Delta period, a nationwide study adjusting for chance of exposure, the Netherlands, July to December 2021.
Euro Surveill;
27(45)2022 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-36367011
16.
Effectiveness of complete primary vaccination against COVID-19 at primary care and community level during predominant Delta circulation in Europe: multicentre analysis, I-MOVE-COVID-19 and ECDC networks, July to August 2021.
Euro Surveill;
27(21)2022 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-35620997
17.
European data sources for computing burden of (potential) vaccine-preventable diseases in ageing adults.
BMC Infect Dis;
21(1): 345, 2021 Apr 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-33849461
18.
Increase in invasive disease caused by Haemophilus influenzae b, the Netherlands, 2020 to 2021.
Euro Surveill;
26(42)2021 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-34676819
19.
Vaccine effectiveness against SARS-CoV-2 transmission to household contacts during dominance of Delta variant (B.1.617.2), the Netherlands, August to September 2021.
Euro Surveill;
26(44)2021 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-34738514
20.
Vaccine effectiveness against SARS-CoV-2 transmission and infections among household and other close contacts of confirmed cases, the Netherlands, February to May 2021.
Euro Surveill;
26(31)2021 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-34355689